Skip to main content

Phio Pharmaceuticals Corp (PHIO) Stock

Phio Pharmaceuticals Corp Stock Details, Movements and Public Alerts

Stock Details

Phio Pharmaceuticals Corp (PHIO), a prominent company in the healthcare sector within the biotechnology industry, is based in USA and primarily trades on the NASDAQ.Currently, the stock is trading at $1.10. Over the past 52 weeks, it has ranged between $0.81 and $3.48. This places the current price at 31.6% of its 52-week high and 35.3% above its 52-week low. Recent trading volume was recorded at 7,566. The 14-day Relative Strength Index (RSI) stands at 52.92, suggesting neutral conditions. The stock is currently trading below its 50-day moving average of $1.10 by 0.00%. Similarly, it is below its 200-day moving average of $1.80 by 38.89%. The MACD histogram is 0.00, indicating neutral momentum0. There are currently 2 active alerts set for PHIO by users.

52-Week Range

$3.48 - $0.81

-68.39% from high · +35.30% from low

Avg Daily Volume

10,993,227

20-day average

100-day avg: 4,129,688

Fundamentals

Valuation Metrics

P/E Ratio (TTM)

N/A

Forward P/E

0.31

Price to Book

0.62

EV/EBITDA

0.61

EPS (TTM)

-$1.38

Price to Sales

48.01

Beta

0.84

Less volatile than market

Q:How is PHIO valued relative to its earnings and growth?
Valuation data is not available for this stock.
Q:What is PHIO's risk profile compared to the market?
With a beta of 0.84, Phio Pharmaceuticals Corp is less volatile than the overall market. This means when the market moves up or down by 10%, this stock typically moves less than 10% in the same direction. Lower beta stocks are often preferred by conservative investors seeking stability. The price-to-book ratio of 0.62 indicates the stock trades below its accounting value, which could signal value or distress.

Performance & Growth

Profit Margin

0.00%

Operating Margin

0.00%

EBITDA

$-11,511,500

Return on Equity

-76.40%

Return on Assets

-46.70%

Revenue Growth (YoY)

0.00%

Earnings Growth (YoY)

0.00%

Q:How profitable and efficient is PHIO's business model?
Profitability metrics are not available for this stock.
Q:What are PHIO's recent growth trends?
Growth data is not available for this stock.

Company Size & Market

Market Cap

$12.4M

Revenue (TTM)

$0

Revenue/Share (TTM)

$0.00

Shares Outstanding

11.62M

Book Value/Share

$1.73

Asset Type

Common Stock

Q:What is PHIO's market capitalization and position?
Phio Pharmaceuticals Corp has a market capitalization of $12.4M, classifying it as a small-cap stock (under $2B). Small-caps offer significant growth potential but come with higher volatility and risk. They can be more sensitive to economic conditions but may provide outsized returns if successful. With 11.62M shares outstanding, the company's ownership is relatively concentrated. As a participant in the BIOTECHNOLOGY industry, it competes with other firms in this sector.
Q:How does PHIO's price compare to its book value?
Phio Pharmaceuticals Corp's book value per share is $1.73, while the current stock price is $1.10, resulting in a price-to-book (P/B) ratio of 0.63. Trading below book value can indicate the market perceives challenges ahead, or it might represent a value opportunity if the assets are quality and earnings can recover. Value investors often screen for P/B ratios below 1.0. As a common stock, this represents equity ownership with voting rights.

Analyst Ratings

Analyst Target Price

$14.00

1172.73% upside potential

Analyst Recommendations

Strong Buy

0

Buy

1

Hold

0

Sell

0

Strong Sell

0

Q:How reliable are analyst predictions for PHIO?
1 analysts cover PHIO with 100% recommending buy/strong buy ratings. Analyst predictions have mixed reliability - studies show consensus rarely beats market returns consistently. The strong bullish consensus may already be priced in. The consensus target of $14.00 implies 1172.7% upside, but targets are often adjusted to follow price moves rather than predict them.
Q:What is the Wall Street consensus on PHIO?
Current analyst recommendations:01 Buy, 000The bullish tilt suggests optimism about future prospects, though investors should conduct independent research.Remember that analyst opinions often lag price movements and can be influenced by investment banking relationships.

Fundamentals last updated: May 17, 2026, 02:23 AM

Technical Indicators

RSI (14-day)

52.92

Neutral

50-Day Moving Average

$1.10

0.00% below MA-50

200-Day Moving Average

$1.80

-38.89% below MA-200

MACD Line

N/A

MACD Signal

N/A

MACD Histogram

N/A

Neutral

Q:What does PHIO's RSI value tell investors?
The RSI (Relative Strength Index) for PHIO is currently 52.92, indicating the stock is in neutral territory (40-60 range). Neither buyers nor sellers have clear control, suggesting consolidation or balanced market forces. Combined with the price being below the 50-day moving average, this shows mixed signals requiring careful analysis.
Q:How should traders interpret PHIO's MACD and moving average crossovers?
MACD analysis shows the MACD line at 0.00 below the signal line at 0.00, with histogram at 0.00. This bearish crossover indicates downward pressure. The narrow histogram suggests a potential trend change ahead. The 50-day MA ($1.10) is below the 200-day MA ($1.80), forming a death cross pattern that often warns of extended weakness. Price is currently between the MAs, suggesting transition.

Indicators last updated: Mar 6, 2026, 01:37 AM

Active Alerts

Alert Condition
Price rises above
Threshold
$1.50
Created
Mar 6, 2026, 01:37 AM
Alert Condition
Volume change
Threshold
300%
Created
Mar 6, 2026, 01:36 AM

Stay Ahead of the Market with Phio Pharmaceuticals Corp Alerts

Set up price alerts for Phio Pharmaceuticals Corp and get notified instantly when the price hits your target. Never miss an important price movement again.